These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25138356)

  • 21. Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis.
    Mizushima T; Ito T; Kishi D; Kai Y; Tamagawa H; Nezu R; Kiyono H; Matsuda H
    Inflamm Bowel Dis; 2004 May; 10(3):182-92. PubMed ID: 15290910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with the immunomodulator FTY720 (fingolimod) significantly reduces renal inflammation in murine unilateral ureteral obstruction.
    Thangada S; Shapiro LH; Silva C; Yamase H; Hla T; Ferrer FA
    J Urol; 2014 May; 191(5 Suppl):1508-16. PubMed ID: 24679864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
    Chiba K
    Yakugaku Zasshi; 2009 Jun; 129(6):655-65. PubMed ID: 19483408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells.
    Morris MA; McDuffie M; Nadler JL; Ley K
    Autoimmunity; 2011 Mar; 44(2):115-28. PubMed ID: 20695767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
    Bail K; Notz Q; Rovituso DM; Schampel A; Wunsch M; Koeniger T; Schropp V; Bharti R; Scholz CJ; Foerstner KU; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2017 Jul; 14(1):148. PubMed ID: 28738885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
    Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ascomycete derivative to MS therapeutic: S1P receptor modulator FTY720.
    Hiestand PC; Rausch M; Meier DP; Foster CA
    Prog Drug Res; 2008; 66():361, 363-81. PubMed ID: 18416311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.
    Chun J; Hartung HP
    Clin Neuropharmacol; 2010; 33(2):91-101. PubMed ID: 20061941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination.
    Lane TE; Liu MT; Chen BP; Asensio VC; Samawi RM; Paoletti AD; Campbell IL; Kunkel SL; Fox HS; Buchmeier MJ
    J Virol; 2000 Feb; 74(3):1415-24. PubMed ID: 10627552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure.
    Metzler B; Gfeller P; Wieczorek G; Li J; Nuesslein-Hildesheim B; Katopodis A; Mueller M; Brinkmann V
    Int Immunol; 2008 May; 20(5):633-44. PubMed ID: 18343890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fingolimod modulates microglial activation to augment markers of remyelination.
    Jackson SJ; Giovannoni G; Baker D
    J Neuroinflammation; 2011 Jul; 8():76. PubMed ID: 21729281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection.
    Commodaro AG; Pedregosa JF; Peron JP; Brandão W; Rizzo LV; Bueno V
    Clinics (Sao Paulo); 2012 Jul; 67(7):805-13. PubMed ID: 22892927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis.
    Butchi N; Kapil P; Puntambekar S; Stohlman SA; Hinton DR; Bergmann CC
    J Virol; 2015 Sep; 89(18):9299-312. PubMed ID: 26136579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation.
    Hla T; Brinkmann V
    Neurology; 2011 Feb; 76(8 Suppl 3):S3-8. PubMed ID: 21339489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators.
    Sehrawat S; Rouse BT
    J Immunol; 2008 Jun; 180(11):7636-47. PubMed ID: 18490766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fingolimod modulates peripheral effector and regulatory T cells in MS patients.
    Serpero LD; Filaci G; Parodi A; Battaglia F; Kalli F; Brogi D; Mancardi GL; Uccelli A; Fenoglio D
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1106-13. PubMed ID: 23649711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
    Hu Y; Lee X; Ji B; Guckian K; Apicco D; Pepinsky RB; Miller RH; Mi S
    Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
    Pereira FV; Arruda DC; Figueiredo CR; Massaoka MH; Matsuo AL; Bueno V; Rodrigues EG
    Clinics (Sao Paulo); 2013 Jul; 68(7):1018-27. PubMed ID: 23917669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.
    Bergmann CC; Altman JD; Hinton D; Stohlman SA
    J Immunol; 1999 Sep; 163(6):3379-87. PubMed ID: 10477608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTY720 regulates bone marrow egress of eosinophils and modulates late-phase skin reaction in mice.
    Sugita K; Kabashima K; Sakabe J; Yoshiki R; Tanizaki H; Tokura Y
    Am J Pathol; 2010 Oct; 177(4):1881-7. PubMed ID: 20802177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.